Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis

This study is testing fecal microbiota transplantation (FMT) — a treatment where stool from a healthy donor is transferred to a patient — as a way to treat active ulcerative colitis (UC), a chronic inflammatory bowel disease. Researchers want to see if FMT can help calm inflammation in the colon. **You may be eligible if...** - You have a diagnosis of active ulcerative colitis with moderate symptoms - You are willing and able to receive enemas or take capsules orally - You are not pregnant or breastfeeding and use effective birth control if applicable - You have an attending physician managing your non-FMT care **You may NOT be eligible if...** - Your ulcerative colitis is severe (high Mayo score) - You are pregnant or planning to become pregnant during the study - You have taken systemic antibiotics in the past 2 weeks - You have active HIV, Hepatitis B, or Hepatitis C - You have a history of other significant bowel conditions (IBS, celiac disease, Crohn's disease, colostomy, etc.) - You have a weakened immune system - You have had a previous FMT in the past 6 months Talk to your doctor to see if this trial is right for you.